Stay Tuned to the LDL Controversy

March 2017

Debate continues about the role of LDL levels in statin patients.

We know the new thinking is to use target DOSES of statins to reduce CV risk...instead of titrating to a specific LDL goal.

But don't recommend a "fire and forget" approach.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Gastroenterology You'll See More "Concomitant" Quadruple Therapy for H. pylori
Insulin Explain How Different Insulins Compare
Travel Medicine Help Patients Prepare for Travel-Related Illnesses
Allergic Reactions Evaluate if Patients Are Really Allergic to Penicillin
Women's Health Continue to Avoid ACE Inhibitors in Women Who May Become Pregnant
Iron Recommend Ferrous Sulfate or Ferrous Fumarate When Oral Iron Is Needed
Cardiology Avoid QT-Prolonging Meds in High-Risk Patients
Asthma Help Ensure Asthma Patients Have the Right Exacerbation Meds On Hand
Cholesterol Stay Tuned to the LDL Controversy
Pulmonary What to Expect With Meds for Pulmonary Arterial Hypertension
Ear Health Explain It's Usually Better to Leave Earwax Alone
Medication Errors Be Cautious With Drug Names That End in the Letter "L"
Practice You'll soon see a new and improved website for Pharmacist's Letter